Financing, Equity Capital Markets
Fulgent Genetics, Inc.
11/19
|
$30.0 Million
Âé¶¹´«Ã½ served as left bookrunner for Fulgent Genetics, Inc. on a confidentially marketed follow-on offering
Sub-Type
CMFO
Sector
Sub-Sector
Life Sciences Tools & Diagnostics